Leeward Investments LLC MA purchased a new position in Agilent Technologies, Inc. (NYSE:A – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 90,754 shares of the medical research company’s stock, valued at approximately $12,349,000.
Other institutional investors have also recently bought and sold shares of the company. Board of the Pension Protection Fund purchased a new position in Agilent Technologies in the 4th quarter worth about $27,000. Navalign LLC purchased a new position in Agilent Technologies in the 4th quarter worth about $27,000. Physician Wealth Advisors Inc. increased its stake in Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock worth $30,000 after purchasing an additional 196 shares in the last quarter. Torren Management LLC purchased a new position in Agilent Technologies during the 4th quarter valued at about $32,000. Finally, State of Wyoming purchased a new position in Agilent Technologies during the 2nd quarter valued at about $35,000.
Agilent Technologies Stock Up 0.4%
A opened at $113.23 on Friday. The business has a 50 day moving average price of $115.24 and a 200 day moving average price of $130.81. Agilent Technologies, Inc. has a twelve month low of $107.07 and a twelve month high of $160.27. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.07. The firm has a market cap of $32.00 billion, a P/E ratio of 24.99, a price-to-earnings-growth ratio of 2.37 and a beta of 1.22.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on A. Wall Street Zen cut Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Morgan Stanley lowered their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. UBS Group lowered their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company lowered their target price on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Finally, Barclays lowered their target price on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $163.71.
View Our Latest Report on Agilent Technologies
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
- Five stocks we like better than Agilent Technologies
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
